Richard Whitley to Cytomegalovirus Infections
This is a "connection" page, showing publications Richard Whitley has written about Cytomegalovirus Infections.
Connection Strength
3.921
-
Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat? Pediatr Infect Dis J. 2019 06; 38(6S Suppl 1):S60-S63.
Score: 0.650
-
The use of antiviral drugs during the neonatal period. Clin Perinatol. 2012 Mar; 39(1):69-81.
Score: 0.390
-
Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res. 2009 Sep; 83(3):207-13.
Score: 0.323
-
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother. 2009 May; 63(5):862-7.
Score: 0.320
-
Cytomegalovirus and HIV: inextricably entwined pathogens. Lancet. 2004 Jun 26; 363(9427):2101-2.
Score: 0.231
-
Congenital cytomegalovirus infection: epidemiology and treatment. Adv Exp Med Biol. 2004; 549:155-60.
Score: 0.223
-
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
Score: 0.151
-
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997 May; 175(5):1080-6.
Score: 0.141
-
Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. Antiviral Res. 1996 Nov; 32(3):119-40.
Score: 0.136
-
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015 Mar 05; 372(10):933-43.
Score: 0.121
-
Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant. 2012 Sep; 16(6):627-37.
Score: 0.100
-
Novel pharmacological strategies in the treatment of life-threatening cytomegalovirus infections. Clinical experience with continuous infusion 9-(1,3-dihydroxy-2-propoxymethyl) guanine. Ann N Y Acad Sci. 1990; 616:452-60.
Score: 0.085
-
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec; 46 Suppl 4:S22-6.
Score: 0.083
-
Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007. Herpes. 2008 Oct; 15(1):4-12.
Score: 0.078
-
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008 Mar 15; 197(6):836-45.
Score: 0.075
-
Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections? Ann Intern Med. 1988 Mar; 108(3):452-4.
Score: 0.075
-
Therapy of herpes virus infections in children. Adv Exp Med Biol. 2008; 609:216-32.
Score: 0.074
-
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun; 81(6):867-72.
Score: 0.070
-
Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985 Nov 14; 313(20):1270-4.
Score: 0.064
-
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis. 2005 Jan 15; 191(2):227-33.
Score: 0.060
-
Therapeutic approaches to the control of cytomegalovirus infections. Birth Defects Orig Artic Ser. 1984; 20(1):345-52.
Score: 0.056
-
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003 Jul; 143(1):16-25.
Score: 0.054
-
Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol. 1997 Mar; 24(1):267-83.
Score: 0.035
-
Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother. 1996 Sep; 40(9):2202-5.
Score: 0.034
-
Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection. J Pediatr. 1976 Jul; 89(1):16-22.
Score: 0.033
-
A rabbit model for human cytomegalovirus-induced chorioretinal disease. J Infect Dis. 1993 Aug; 168(2):336-44.
Score: 0.027
-
Diabetes insipidus associated with symptomatic congenital cytomegalovirus infection. J Pediatr. 1993 Jun; 122(6):911-3.
Score: 0.027
-
Acyclovir: the past ten years. Adv Exp Med Biol. 1990; 278:243-53.
Score: 0.021
-
Congenital cytomegalovirus: immunological alterations. J Med Virol. 1987 Sep; 23(1):41-9.
Score: 0.018
-
Transfusion-associated viral infections. Curr Probl Pediatr. 1987 Jul; 17(7):391-443.
Score: 0.018
-
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics. 1987 Jan; 79(1):76-83.
Score: 0.017
-
Herpesvirus infections in the immunocompromised host: diagnosis and management. Adv Exp Med Biol. 1986; 202:95-118.
Score: 0.016
-
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis. 1983 Jun; 147(6):1119-20.
Score: 0.013
-
Preventive and therapeutic approaches to the newborn infant with perinatal viral and toxoplasma infections. Clin Perinatol. 1981 Oct; 8(3):591-604.
Score: 0.012
-
Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect Immun. 1981 Oct; 34(1):166-70.
Score: 0.012
-
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics. 1981 Sep; 68(3):322-9.
Score: 0.012
-
Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft. J Infect Dis. 1980 Jul; 142(1):9-17.
Score: 0.011
-
Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation. Transplantation. 1979 Dec; 28(6):443-6.
Score: 0.011
-
Outcome of renal transplantation in patients with primary cytomegalovirus infection. Transplant Proc. 1979 Jun; 11(2):1288-90.
Score: 0.010
-
Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections. Adv Ophthalmol. 1979; 38:288-96.
Score: 0.010
-
Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis. 1978 May; 137(5):556-63.
Score: 0.009
-
Cerebellar hypoplasia in an infant with congenital cytomegalovirus infection. Pediatrics. 1976 Jan; 57(1):155-7.
Score: 0.008
-
Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis. 1974 Jul; 130(1):32-9.
Score: 0.007